Literature DB >> 22329799

Role and function of macrophages in the metabolic syndrome.

Prerna Bhargava1, Chih-Hao Lee.   

Abstract

Macrophages are key innate immune effector cells best known for their role as professional phagocytes, which also include neutrophils and dendritic cells. Recent evidence indicates that macrophages are also key players in metabolic homoeostasis. Macrophages can be found in many tissues, where they respond to metabolic cues and produce pro- and/or anti-inflammatory mediators to modulate metabolite programmes. Certain metabolites, such as fatty acids, ceramides and cholesterol crystals, elicit inflammatory responses through pathogen-sensing signalling pathways, implicating a maladaptation of macrophages and the innate immune system to elevated metabolic stress associated with overnutrition in modern societies. The outcome of this maladaptation is a feedforward inflammatory response leading to a state of unresolved inflammation and a collection of metabolic pathologies, including insulin resistance, fatty liver, atherosclerosis and dyslipidaemia. The present review summarizes what is known about the contributions of macrophages to metabolic diseases and the signalling pathways that are involved in metabolic stress-induced macrophage activation. Understanding the role of macrophages in these processes will help us to develop therapies against detrimental effects of the metabolic syndrome.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22329799     DOI: 10.1042/BJ20111708

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  41 in total

Review 1.  Expanding role of delta-like 4 mediated notch signaling in cardiovascular and metabolic diseases.

Authors:  Daiju Fukuda; Masanori Aikawa
Journal:  Circ J       Date:  2013-09-12       Impact factor: 2.993

2.  "Velcro" engineering of high affinity CD47 ectodomain as signal regulatory protein α (SIRPα) antagonists that enhance antibody-dependent cellular phagocytosis.

Authors:  Chia Chi M Ho; Nan Guo; Jonathan T Sockolosky; Aaron M Ring; Kipp Weiskopf; Engin Özkan; Yasuo Mori; Irving L Weissman; K Christopher Garcia
Journal:  J Biol Chem       Date:  2015-04-02       Impact factor: 5.157

Review 3.  Imaging macrophages with nanoparticles.

Authors:  Ralph Weissleder; Matthias Nahrendorf; Mikael J Pittet
Journal:  Nat Mater       Date:  2014-02       Impact factor: 43.841

Review 4.  Aggressive Crosstalk Between Fatty Acids and Inflammation in Macrophages and Their Influence on Metabolic Homeostasis.

Authors:  Kazuhiro Nishiyama; Yasuyuki Fujimoto; Tadayoshi Takeuchi; Yasu-Taka Azuma
Journal:  Neurochem Res       Date:  2017-04-19       Impact factor: 3.996

5.  Delivery of negatively charged liposomes into the atherosclerotic plaque of apolipoprotein E-deficient mouse aortic tissue.

Authors:  Siqin Zhaorigetu; Cristian Rodriguez-Aguayo; Anil K Sood; Gabriel Lopez-Berestein; Brian L Walton
Journal:  J Liposome Res       Date:  2014-01-20       Impact factor: 3.648

Review 6.  Delta-Like Ligand 4-Notch Signaling in Macrophage Activation.

Authors:  Toshiaki Nakano; Daiju Fukuda; Jun-Ichiro Koga; Masanori Aikawa
Journal:  Arterioscler Thromb Vasc Biol       Date:  2016-08-25       Impact factor: 8.311

7.  Obesity and metabolic syndrome related macrophage promotes PD-L1 expression in TNBC through IL6/JAK/STAT pathway and can be reversed by telmisartan.

Authors:  Ying Wang; Xin Zhang; Xin Xie; Wei Chen; Min Li; Dongmei Diao; Chengxue Dang
Journal:  Cancer Biol Ther       Date:  2020-11-20       Impact factor: 4.742

Review 8.  Neuroimmunology of the atherosclerotic plaque: a morphological approach.

Authors:  Rita Businaro
Journal:  J Neuroimmune Pharmacol       Date:  2012-11-14       Impact factor: 4.147

9.  Spinal cord injury causes chronic liver pathology in rats.

Authors:  Andrew D Sauerbeck; J Lukas Laws; Veera V R Bandaru; Phillip G Popovich; Norman J Haughey; Dana M McTigue
Journal:  J Neurotrauma       Date:  2014-10-21       Impact factor: 5.269

10.  Emodin attenuates systemic and liver inflammation in hyperlipidemic mice administrated with lipopolysaccharides.

Authors:  Xuemei Jia; Stephen Iwanowycz; Junfeng Wang; Fatma Saaoud; Fang Yu; Yuzhen Wang; Jun Hu; Saurabh Chatterjee; Qian Wang; Daping Fan
Journal:  Exp Biol Med (Maywood)       Date:  2014-04-16
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.